tiprankstipranks
Advertisement
Advertisement
Intellia Therapeutics rises 10.7%
PremiumThe FlyIntellia Therapeutics rises 10.7%
1M ago
Midday Fly By: Fox to acquire Roku, Salesforce to buy Fin
Premium
The Fly
Midday Fly By: Fox to acquire Roku, Salesforce to buy Fin
1M ago
Sell Rating Maintained on Clinical and Commercial Uncertainty; $9 Price Target Reaffirmed
Premium
Ratings
Sell Rating Maintained on Clinical and Commercial Uncertainty; $9 Price Target Reaffirmed
1M ago
Intellia Therapeutics: Buy Rating Reiterated on De-Risked HAE and ATTR Pipelines; $29 DCF-Based Price Target Maintained
PremiumRatingsIntellia Therapeutics: Buy Rating Reiterated on De-Risked HAE and ATTR Pipelines; $29 DCF-Based Price Target Maintained
2M ago
Intellia Therapeutics price target raised to $17 from $13 at Bernstein
Premium
The Fly
Intellia Therapeutics price target raised to $17 from $13 at Bernstein
2M ago
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
Premium
The Fly
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
2M ago
Myles Minter Reiterates Buy on Intellia (NTLA), Citing Extended Cash Runway and Strong Phase III Data for Lonvoguran Ziclumeran
PremiumRatingsMyles Minter Reiterates Buy on Intellia (NTLA), Citing Extended Cash Runway and Strong Phase III Data for Lonvoguran Ziclumeran
2M ago
Cathie Wood’s ARK Investment buys 141K shares of Intellia Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment buys 141K shares of Intellia Therapeutics today
3M ago
Intellia Therapeutics Prices Public Equity Offering to Fund Pipeline
Premium
Company Announcements
Intellia Therapeutics Prices Public Equity Offering to Fund Pipeline
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100